United States · FDA National Drug Code directory

CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72162-2436_bf5abb7c-5ad5-4817-8d72-0b1ae5a52741
Product NDC
72162-2436
Form
CAPSULE
Composition / generic term
CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20221001
Source listing expiry
20261231

Source-listed ingredients

  • CHLORDIAZEPOXIDE HYDROCHLORIDE — 5 mg/1
  • CLIDINIUM BROMIDE — 2.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 CAPSULE in 1 BOTTLE (72162-2436-1) · 72162-2436-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →